Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study
American Journal of Hypertension · 14.08.2025 · 38 (9) · 675-685
DOI: 10.1093/ajh/hpaf077 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Hypertension, online erschienen am 06.05.2025. Verfasst von Guo Ji und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, School of Clinical Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, China. Hauptthemen laut MEDLINE: Hyperaldosteronism, Blood Pressure, Adrenal Glands, Embolization, Therapeutic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Adrenal artery embolization (AAE) has been shown to reduce blood pressure (BP) and correct biochemical abnormalities in patients with idiopathic hyperaldosteronism (IHA) during short-term 6–12-month follow-ups. This study aimed to evaluate the long-term efficacy and safety of unilateral AAE over a 24-month period. METHODS The prospective study included 109 IHA patients undergoing unilateral AAE, with 94 completing the 24-month follow-up. Evaluations included office, home and 24-hour ambulatory BP, biochemical markers, renal function, and cardiac function (echocardiography). Medication use and adverse events were documented. RESULTS At the 24-month follow-up, the office, home, and 24-hour ambulatory systolic BP values decreased by 17.3 ± 23.1, 16.4 ± 21.9, and 9.9 ± 18.6 mmHg, respectively (all P < 0.001), and the diastolic BP values decreased by 8.8 ± 16.1, 7.1 ± 15.8, and 6.4 ± 11.1 mmHg (all P < 0.001). The complete and partial clinical success rates were 14.9% and 50.0%, respectively, whereas those for biochemical success were 13.6% and 45.5%. Abnormal biochemical characteristics, including elevated plasma aldosterone levels, increased aldosterone‒renin ratios (ARRs), plasma renin suppression, and hypokalemia, were significantly improved (all P < 0.01). Improvements in cardiac remodeling and left ventricular (LV) diastolic function were observed, particularly in those with elevated LV mass index (P < 0.05). No evidence of renal impairment or long-term safety concerns was observed. CONCLUSION Unilateral AAE in IHA patients promotes sustained BP reduction, biochemical correction, improved cardiac remodeling, and enhanced LV diastolic function over 24 months, with no significant long-term safety concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, School of Clinical Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, China.
- Key Laboratory of Aging and Vascular Homeostasis at Chengdu Medical College of Sichuan Province, Chengdu, Sichuan, China.
- Clinical Research Center for Geriatrics of Sichuan Province, Chengdu, Sichuan, China.
- School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China.
ORCID-Profile: Yaqiong Zhou, Peijian Wang
Zitieren
APA
Ji, G., Liu, S., Wan, J., Zhou, Y., Yang, C., Wang, X., He, G., Zeng, A., Zhang, L., Luo, T., Yang, Y., Wang, D., Feng, K., Hou, J., & Wang, P. (2025). Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study. American Journal of Hypertension, 38(9), 675-685. https://doi.org/10.1093/ajh/hpaf077
Vancouver
Ji G, Liu S, Wan J, Zhou Y, Yang C, Wang X, et al. Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study. American Journal of Hypertension. 2025;38(9):675-685. doi:10.1093/ajh/hpaf077
BibTeX
@article{Ji2025,
author = {Ji, Guo and Liu, Sen and Wan, Jindong and Zhou, Yaqiong and Yang, Changqiang and Wang, Xinquan and He, Gaomin and Zeng, Anping and Zhang, Lingling and Luo, Tao and Yang, Yi and Wang, Dan and Feng, Kaige and Hou, Jixin and Wang, Peijian},
title = {Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study},
journal = {American Journal of Hypertension},
year = {2025},
volume = {38},
number = {9},
pages = {675--685},
doi = {10.1093/ajh/hpaf077}
}
EUVIMED